TP53 and colorectal cancer: Higher concentrations suppress Sirt-1, enhancing p53 acetylation, and apoptosis in wild-type colorectal cancer cells, suggesting a novel negative regulatory interplay between p53 and Sirt-1 in resveratrol-treated colorectal cancer [149].